2. Academic Validation
  3. Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

  • Am J Respir Crit Care Med. 2022 Nov 1;206(9):1166-1168. doi: 10.1164/rccm.202205-0868LE.
Ganesh Raghu 1,  Majd Mouded 2,  Antje Prasse 3,  Christopher Stebbins 2,  Guolin Zhao 2,  Guochen Song 2,  Million Arefayene 2,  Shelia M Violette 2,  Diana Gallagher 2,  Kevin F Gibson 4
Affiliations

Affiliations

  • 1 Center for Interstitial Lung Diseases University of Washington Medical Center Seattle, Washington.
  • 2 Biogen, Inc. Cambridge, Massachusetts.
  • 3 Department of Pneumology Medical School of Hannover Hannover, Germany.
  • 4 Division of Pulmonary, Allergy, and Critical Care Medicine University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania.
PMID: 35830489 DOI: 10.1164/rccm.202205-0868LE
Figures
Products